化合物 SB203580,Adezmapimod
  • 化合物 SB203580,Adezmapimod

化合物 SB203580|T1764

价格 297 488 783
包装 5mg 10mg 25mg
最小起订量 1mg
发货地 上海
更新日期 2024-09-14
QQ交谈 微信洽谈

产品详情

中文名称:化合物 SB203580英文名称:Adezmapimod
CAS:152121-47-6品牌: TargetMol
产地: 美国保存条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格: 99.87%产品类别: 抑制剂
货号: T1764
2024-09-14 化合物 SB203580 Adezmapimod 5mg/297RMB;10mg/488RMB;25mg/783RMB 297 TargetMol 美国 Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. 99.87% 抑制剂

Product Introduction

Bioactivity

名称Adezmapimod
描述Adezmapimod (SB 203580) is a p38 MAPK inhibitor (IC50=0.3-0.5 μM) that is selective and ATP-competitive. Adezmapimod possesses autophagy and mitochondrial autophagy activating activity. Adezmapimod displays more than 100-fold higher selectivity than PKB, LCK, and GSK-3β.
细胞实验The luciferase reporter plasmid pIL6luc(-122) and the CAT reporter plasmid p(TRE)5CAT were transfected into TF-1 cell line by means of electroporation. Prior to transfection, cells were cultured for 16?h at a density of 0.5×10^6 cells/ml in the appropriate medium, washed twice and resuspended in RPMI 1640 at a density of 10×10^6 in 200?μl. When transfected with a single plasmid, 25?μg of DNA was added and the mixture was left at room temperature for 15?min. Cotransfections were performed with 15?μg of the reporter plasmid pIL6luc(-122) together with 15?μg of the dominant-negative expression plasmids (pRSV-MKK3(Ala), pcDNA3-MKK6(K82A), pRSV-NΔRaf1, pcDNA3-MKK4(Ala), pcDNA3-Flag-JNK1, or pcDNA3 (empty vector). Cotransfections of pGAL4tkluc (5?μg) with either pGAL4p65 (5?μg) or pGAL4dbd (5?μg) were performed under similar conditions. In addition, cells were cotransfected with 2?μg of a CMV-CAT plasmid, to normalize for transfection efficiency. Electroporation, in 0.4?cm electroporation cuvettes, was performed at 240?V and 960?μF with Gene Pulser electroporator. After electroporation, the cells were replated in RPMI 1640 containing 2% FBS. Six hours after transfection cells were stimulated for 24?h with medium or OA (30?ng/ml) or SB203580 for 30?min prior to OA stimulation. The cells were then harvested and lysed by commercially available luciferase lysis buffer. One-hundred μl of lysis product was added to 100?μl of luciferase assay reagents and luciferase activity was measured with the Anthos Lucy1 luminometer. CAT reporter activity of 100?μl lysis product plus 100?μl CAT dilution buffer was determined with a commercially available CAT Elisa kit [3].
激酶实验Cells were lysed in Buffer A for Western blotting and PKB kinase assays. Kinase assays were performed according to the manufacturer's instructions. Briefly, 4 μg of sheep anti-PKBα was immobilized on 25 μl of protein G-Sepharose overnight (or 1.5 h) and washed in Buffer A (50 mM Tris, pH 7.5, 1 mM EDTA, 1 mMEGTA, 0.5 mM Na3VO4, 0.1% β-mercaptoethanol, 1% Triton X-100, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 0.1 mM phenylmethylsulfonyl fluoride, 1 μg/ml aprotinin, pepstatin, leupeptin, and 1 μM microcystin). The immobilized anti-PKB was then incubated with 0.5 ml of lysate (from 5 × 10^6 cells) for 1.5 h and washed three times in 0.5 ml of Buffer A supplemented with 0.5 M NaCl, two times in 0.5 ml of Buffer B (50 mM Tris-HCl, pH 7.5, 0.03% (w/v) Brij-35, 0.1 mM EGTA, and 0.1% β-mercaptoethanol), and twice with 100 μl of assay dilution buffer; 5× assay dilution buffer is 100 mM MOPS, pH 7.2, 125 mMβ-glycerophosphate, 25 mM EGTA, 5 mM sodium orthovanadate, 5 mM DTT. To the PKB enzyme immune complex was added 10 μl of assay dilution buffer, 40 μM protein kinase A inhibitor peptide, 100 μM PKB-specific substrate peptide, and 10 μCi of [γ-32P]ATP, all made up in assay dilution buffer. The reaction was incubated for 20 min at room temperature with shaking, then samples were pulse spun, and 40 μl of reaction volume were removed into another tube to which was added 20 μl of 40% trichloroacetic acid to stop the reaction. This was mixed and incubated for 5 min at room temperature, and 40 μl was transferred onto P81 phosphocellulose paper and allowed to bind for 30 s. The P81 pieces were washed three times in 0.75% phosphoric acid then in acetone at room temperature. γ-32P incorporation was then measured by scintillation counting [1].
动物实验In survival studies, C57BL/6J mice weighing 20 g to 30 g were briefly anesthetized with isoflurane and challenged with 0.05 mL of IT normal saline (NS, noninfected controls) or E. coli (15 × 10^9 CFU/kg) as previously described. One hour before NS challenge, mice (n = 24) received either intraperitoneal SB203580 (100 mg/kg in 0.25 mL) or diluent only (placebo). Infected animals received SB203580 in doses of 100, 10, 1, or 0.1 mg/kg or placebo 1 hour before IT E. coli (n = 241); SB203580 100 or 0.1 mg/kg or placebo 1 hour after E. coli (n = 121); or SB203580 100 mg/kg or placebo 12 hours after E. coli (n = 72). All animals received ceftriaxone (100 mg/kg in 0.1 mL, subcutaneously) for 4 days and NS (0.5 mL, subcutaneously) for 1 day beginning 4 hours after challenge. Animals were observed every 2 hours for the initial 48 hours, every 4 hours from 48 hours to 72 hours, every 8 hours from 72 hours to 96 hours, and then twice daily until study completion (168 hours). Sequential weekly experiments with 24 animals each compared either two to three doses of SB203580 versus placebo administered at similar times or similar doses of SB203580 versus placebo at differing treatment times. Study groups in each experiment were of equivalent sample size (i.e., 6 – 8 per group) [5].
体外活性方法:人肝癌细胞 HepG2 用 Adezmapimod (0.1-20 μM) 处理 30 min,使用 Western Blot 方法检测靶点蛋白表达水平。 结果:Adezmapimod 剂量依赖性地激活 ERK,但不激活 p38 和 JNK。ERK 的最大活化是在 1- 10 μM 之间。[1] 方法:CD4+T 细胞用 Adezmapimod (1-25 μM) 处理 72 h,使用 Flow Cytometry 方法分析 Tregs 的增殖。 结果:Adezmapimod 以剂量依赖的方式抑制 TNF 诱导的 Tregs 增殖,抑制率为32.0-73.2%。Adezmapimod 处理也显著降低了培养的 CD4+T 细胞中 Foxp3+ Treg 的比例,抑制率为24.9-47.05%。[2]
体内活性方法:为检测体内活性,将 Adezmapimod (25 mg/kg in 4% DMSO+30% PEG 300+5% Tween 80+61% ddH2O) 单次腹腔注射给 LPS 处理的 C57BL/6J 小鼠,24 和 72 h 后,处死小鼠。 结果:通过 Adezmapimod 的处理,LPS 诱导的 Tregs 上 Ki-67 和 TNFR2 表达的上调被完全消除。在 LPS 处理的小鼠中,Adezmapimod 对 Tregs 增殖扩增的抑制作用可以持续至少 72 h。[2] 方法:检测对子宫内膜异位症 (EM) 发育的影响,将 Adezmapimod (1 μg/mg) 腹腔注射给诱导 EM 的 BALB/c 小鼠,每天一次,持续二十四天。 结果:Adezmapimod 降低了小鼠子宫内膜异位病变的重量和大小。与 EM 组相比,Adezmapimod 组腹膜细胞的 IL-1β、TNF-α、MMP-2 和 MMP-9 水平降低。EM 组 p38 MAPK 的磷酸化水平升高,Adezmapimod 下调了磷酸化水平。[3]
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度10% DMSO+40% PEG300+5% Tween 80+45% Saline : 5 mg/mL (13.25 mM), Working solution is recommended to be prepared and used immediately.
DMSO : 50 mg/mL (132.47 mM)
1eq. HCl : 37.7 mg/mL (100 mM)
关键字Inhibitor | PKBα | inhibit | SAPK2a | GSK3β | Mitophagy | p38 MAPK | Mitochondrial Autophagy | Autophagy | SB-203580 | Adezmapimod | PB-203580 | SB 203580 | RWJ64809 | PB203580 | LCK | SAPK2b | RWJ-64809 | ATP-competitive
相关产品Oxyresveratrol | Guanidine hydrochloride | Naringin | Taurine | Gefitinib | Xylitol | Hydroxychloroquine | Curcumin | Stavudine | Myricetin | Paeonol | Sodium 4-phenylbutyrate
相关库抑制剂库 | 经典已知活性库 | 抗癌活性化合物库 | 抗癌化合物库 | 已知活性化合物库 | 抗胰腺癌化合物库 | 激酶抑制剂库 | 抗衰老化合物库 | 疼痛相关化合物库 | 抗代谢疾病化合物库
关键字: PB 203580|||4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑|||RWJ 64809|||SB203580|TargetMol

公司简介

上海陶术生物科技有限公司为美国Target Molecule Corp. ( Target Mol ) 在上海建立的全资子公司。我们与美国波士顿、德国慕尼黑的同事一起,为北美、欧洲和亚洲从事药物研发和生物学研究的科学家提供优质的产品和专业的服务。公司下设筛选事业部,化学事业部,生物事业部和新材料部。 从虚拟筛选到实体化合物分子供应;从商业化产品销售到个性化定制合成;从对明确靶点的分子筛选到对明确分子的多靶点筛选,从高通量筛选到化学结构优化,我们都可以满足您的科研用品及技术服务的需求。 经过在中国市场五年的精心耕耘,我们已成为筛选化合物领域优秀的供应商,为超过五百家学校和各类企业提供了品质卓越的小分子化合物和药物筛
成立日期 2013-04-18 (12年) 注册资本 566.2651万人民币
员工人数 100-500人 年营业额 ¥ 1亿以上
主营行业 化学试剂,生物活性小分子 经营模式 贸易,试剂,定制,服务
  • TargetMol中国(陶术生物)
VIP 12年
  • 公司成立:12年
  • 注册资本:566.2651万人民币
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:小分子抑制剂,药物筛选化合物库,天然产物,活性分子化合物等
  • 公司地址:上海市闸北区江场三路28号4楼
询盘

化合物 SB203580|T1764相关厂家报价

更多
产品名称 价格   公司名称 报价日期
询价
VIP4年
四川省维克奇生物科技有限公司
2024-10-18
¥621
VIP13年
湖南汇百侍生物科技有限公司
2024-10-11
询价
VIP11年
南京百鑫德诺生物科技有限公司
2024-09-26
¥375.90
VIP1年
上海阿拉丁生化科技股份有限公司
2024-08-16
¥955.90
VIP12年
上海阿拉丁生化科技股份有限公司
2024-08-16
¥2008.89
北京五洲元业科贸公司
2021-06-27
¥2008.89
北京五洲元业科贸有限公司
2021-06-27
¥2008.89
北京五洲元业科贸有限公司
2021-06-27
¥2008.89
北京五洲元业科贸公司
2021-06-27
¥2008.89
北京五洲元业科贸公司
2021-06-27
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.
400-158-6606